The National Science Foundation-funded effort will address the nationwide shortage of speech-language pathologists, ensure at-risk children receive assistance.
Channavix Therapeutics and Peregrine BioVentures are developing two patent families related to long-lasting, non-opioid, non-addictive pain therapeutics.
'I would like to express our university’s solidarity with UB’s Iranian students and faculty as well as our concern for the safety and liberty of their loved ones in their home country,' he says.